The peptide problem: Hype is outrunning the evidence In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea Compounded "semaglutide" is not FDA approved semaglutide.com